Phorm Sitemap
- Partners.phorm.com/
- Webwise.phorm.com/
- Advertising.phorm.com/
- Investors.phorm.com/
- Privacy.phorm.com/
- News.phorm.com/
- About Us : Phorm : Digital Technology
- About Us : Phorm : Board of Directors
- About Us : Phorm :
Executive Team
- Executive Team : Phorm : Kent Ertugrul
- Executive Team : Phorm : Stratis Scleparis
- Executive Team : Phorm : Daniel Park
- Executive Team : Phorm : Nan Richards
- Executive Team : Phorm : Andrew Croxson
- Executive Team : Phorm : Brooks Dobbs
- Executive Team : Phorm : Sharon O'Leary
- Executive Team : Phorm : Nick Barnett
- Executive Team : Phorm : Karen Arutyunov
- Executive Team : Phorm : Mark Burgess
- Executive Team : Phorm : Chris Hogan
- Executive Team : Phorm : Anton Roslov
- Executive Team : Phorm : Marc Rothschild
- Executive Team
: Phorm : David Sawday
- Locations : Phorm
- Careers : Phorm : Digital Advertising & Marketing
- Phorm Blog
- Frequently Asked Questions
- Inphorm Newsletter
- How Phorm Technology Works
- Privacy Policy
- Contact Us
- Sitemap
- 2008 Final Results
- 2008 Interim Results
- 2007 Final Results
- 2007 Final Results RNS
- 2007 Interim Results
- 2006 Final Results
- 2006 Interim Results
- 2005 Final Results
- 2005 Interim Results
- 2004 Final Results
- Annual Accounts
- Total Voting Rights
- Final Results
- Placing to raise £15 million
- Korean Market Trial
- Apology from "New Media Age" Magazine
- AIM Block Admission
- Phorm Inc Korean Market Trial
- Phorm Inc Grant of Options
- Phorm Inc Grant of Options
- Phorm Inc Change of Broker
- Share Issue - Replacement
- Announcement of Appointments
- Phorm welcomes IAB's Good Practice Principles
- Management Appointments
- BT Trial Update
- Phorm Announces Board Changes
- Disclosure of Share Sale
- Grant of Options
- Cancellation of admission of shares
- Commencement of BT Trial
- Phorm Press Release: BERR Statement
- Phorm Update
- Appointment of Independent Board Chairman
- Transfer of Shares from Unrestricted Line
- Exercise of options
- Annual Report and Accounts
- Notification of Holding
- Notification of Shareholding
- Issue of Equity
- Result of Stockholder Meeting
- Statement re Share Price Movement
- Notification of Holding
- Special Stockholder Meeting
- ISP Agreements
- Exercise of Options
- Transfer of Shares
- Management Appointment
- Exercise of Options
- Director/PDMR Shareholding
- Exercise of Options
- Holding(s) in Company
- Exercise of Options
- Directorate Change
- Notification of Holding
- Website – Rule 26 Compliance
- Director / PDMR Shareholding
- Directorate Change
- Exercise of options
- Notification of Interest
- Additional Listing
- Statement re Share Price Movement
- Notification of Holding
- Directorate Change
- Issue of Equity
- Re-Organisation to Phorm
- Re-Organisation
- Press Speculation
- Result of AGM
- Notification of Holding
- Announcement of Annual Results
- AIM Admission Document
- Exercise of Options
- Schedule 1 - Phorm, Inc
- Notice of AGM
- Directorate Change
- Issue of Equity
- Blocklisting - Interim Review
- Holdings in Company
- Total Voting Rights
- Additional Listing
- Director/PDMR Shareholding
- Additional Listing
- Holdings in Company
- Statement Re Share Price Movement
- Directorate Change
- Additional Listing
- Additional Listing
- Additional Listing
- Additional Listing
- David Dorman appointed as advisor
- Share Incentive Plan
- Update
- Trading in and Settlement of
Restricted Common Shares - Director/PDMR Shareholding
- Update - ISP Partnership Strategy
- Formal Notice
- Appointment of EVP Operations
- Additional Listing
- Director/PDMR Shareholding
- Director/PDMR Shareholding
- Director/PDMR Shareholding
- Trading in and Settlement of Common Shares
- Additional Listing, Warrants-Options
- Director/PDMR Shareholding
- Director/PDMR Shareholding
- Issue of Equity - February 2006
- Blocklisting - Interim Review
- Blocklisting - Interim Review
- Trading Update - January 2006
- Holdings in Company
- Directorate Change
- Statement: wireless ISP agreement
- Result of Stockholders Meeting
- Additional Listing - July 29, 2005
- Placing to raise approx GBP1m
- Additional Listing - July 14, 2005
- Result of AGM - June 2005
- AGM Statement
- Director Shareholding
- Statement re New Technology
- Directorate Change
- Correction: Change of Adviser
- Change of Adviser - April 2005
- Admission to AIM - December 2004
- Phorm Announces Webwise Discover
- Korean Market Trial
- Phorm launches Stopphoulplay.com
- All-Party Parliamentary Group on Communication Investigation into internet traffic
- Master Investor Show
- EU Infringement Proceedings Against UK Government
- Statement
by Department for Business,
Enterprise and Regulatory Reform - Phorm Update
- Phorm
Elects Steven J. Heyer as
Independent Board Chairman - Phorm
Confirms its Commitment to User
Privacy Through 'Chief Privacy Officer'
Appointment - Phorm
Tells FTC It Endorses 'No Retention'
of Consumer Data for the Sake of
Behavioral Advertising - Phorm
welcomes the Article 29 Working Party
decision to enhance internet privacy - Phorm Rejects FIPR Claims
- Internet
Profits Will Rise for Advertisers
and Web Site Owners - BT
PLC, TalkTalk and Virgin Media Inc
confirm exclusive agreements with Phorm
